Illumina Долг / собственный капитал
Что обозначает Долг / собственный капитал в Illumina?
Долг / собственный капитал Illumina, Inc. является 0.42
Какое определение для Долг / собственный капитал?
Соотношение долга к собственному капиталу - это финансовое соотношение, показывающее относительную пропорцию собственного капитала и долга, используемых для финансирования активов компании.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Долг / собственный капитал компаний в Miscellaneous сектор на LSE по сравнению с Illumina
Что делает Illumina?
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California.
Компании с долг / собственный капитал похож на Illumina
- Sandu Pharmaceuticals имеет Долг / собственный капитал из 0.42
- Kader имеет Долг / собственный капитал из 0.42
- Canaan имеет Долг / собственный капитал из 0.42
- Xinyi Glass имеет Долг / собственный капитал из 0.42
- Lundin Ab Spon Adr Each имеет Долг / собственный капитал из 0.42
- Wereldhave Belgium имеет Долг / собственный капитал из 0.42
- Illumina имеет Долг / собственный капитал из 0.42
- New Solar имеет Долг / собственный капитал из 0.42
- Castle Minerals имеет Долг / собственный капитал из 0.42
- Biglari имеет Долг / собственный капитал из 0.42
- ImExHS имеет Долг / собственный капитал из 0.42
- Genesys International имеет Долг / собственный капитал из 0.42
- Konami имеет Долг / собственный капитал из 0.42